“Why Silicon Valley Wants Your Blood: Inside the $100B Longevity Testing Boom” — what this page in the network covers. Tech elites and wellness startups are fueling a surge in at-home and direct-to-consumer blood testing, with the global longevity market projected to hit $100 billion by 2030. Companies like InsideTracker, Levels, and Function Health are capitalizing on a cultural shift toward preventive health, offering panels that track everything from glucose and cholesterol to hormones and heavy metals. The Verge's Victoria Song documents her own six-week, 12-vial testing journey, revealing both the appeal and the anxiety of constant monitoring.
The trend is driven by a desire to optimize performance and extend lifespan, but critics question the clinical value of frequent testing for healthy people. As consumers increasingly seek data-driven health insights, the line between medical necessity and wellness obsession blurs. The full version stays on the original page, which this listing opens directly.